Search Results 771-780 of 17009 for pharmacogenetics
Hematology — Learn about innovative diagnosis and treatment options for blood diseases, including cancers, at Mayo Clinic.
Protocol includes a single treatment with intravenously-delivered allogeneic bone marrow-derived mesenchymal stem cells (BM-MSCs) infusion. Individuals will ...
Inclusion Criteria: Biopsy proven cutaneous mastocytosis with or without evidence of systemic disease. Male and female patients, 18 to 80 years of age.
Below are current clinical trials. 29 studies in Obstetrics and Gynecology (open studies only). Filter this list of studies by location, status and more.
The purpose of this study is to estimate the efficacy of LUTATHERA treatment in patients with recurrent grade 1 meningioma as measured by 6-month PFS rate, ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
Bortezomib may also stop the growth of cancer cells by blocking blood flow to the tumor. Monoclonal antibodies, such as rituximab, can block cancer growth in ...
The purpose of this study is to produce preliminary data testing the feasibility and effectiveness of high intensity interval training (HIIT) on cardiovascular ...
Patient inquiries. The High-Dimensional Phenotyping Lab does not schedule or manage patient appointments directly. If you are a patient, learn how you can ...
Learn how treatments and lifestyle changes might help reduce kidney damage from this disease.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.